The average one-year price target for InnoCare Pharma (SEHK:9969) has been revised to HK$24.11 / share. This is an increase of 20.03% from the prior estimate of HK$20.09 dated November 16, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of HK$20.94 to a high of HK$30.28 / share. The average price target represents an increase of 78.09% from the latest reported closing price of HK$13.54 / share.
What is the Fund Sentiment?
There are 25 funds or institutions reporting positions in InnoCare Pharma. This is an increase of 1 owner(s) or 4.17% in the last quarter. Average portfolio weight of all funds dedicated to 9969 is 0.15%, an increase of 43.33%. Total shares owned by institutions increased in the last three months by 24.61% to 46,267K shares.
What are Other Shareholders Doing?
VGTSX - Vanguard Total International Stock Index Fund Investor Shares holds 14,105K shares representing 0.99% ownership of the company. In its prior filing, the firm reported owning 10,039K shares , representing an increase of 28.83%. The firm increased its portfolio allocation in 9969 by 129.03% over the last quarter.
VEIEX - Vanguard Emerging Markets Stock Index Fund Investor Shares holds 12,762K shares representing 0.89% ownership of the company. In its prior filing, the firm reported owning 9,283K shares , representing an increase of 27.26%. The firm increased its portfolio allocation in 9969 by 113.50% over the last quarter.
IEMG - iShares Core MSCI Emerging Markets ETF holds 6,856K shares representing 0.48% ownership of the company. In its prior filing, the firm reported owning 5,983K shares , representing an increase of 12.73%. The firm increased its portfolio allocation in 9969 by 28.46% over the last quarter.
VFSNX - Vanguard FTSE All-World ex-US Small-Cap Index Fund Institutional Shares holds 3,234K shares representing 0.23% ownership of the company. In its prior filing, the firm reported owning 2,208K shares , representing an increase of 31.73%. The firm increased its portfolio allocation in 9969 by 130.19% over the last quarter.
DFCEX - Emerging Markets Core Equity Portfolio - Institutional Class holds 3,046K shares representing 0.21% ownership of the company. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
